Abstract
Objective Glioblastoma multiforme (GBM) is a nearly uniformly fatal brain tumor with a median recurrence rate of 7 months and survival of 14 months after multimodality treatment. We sought to evaluate outcomes based on the presence or absence of symptoms at the time of recurrence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have